Nath Bio-Genes (India) Ltd (NSE: NATHBIOGEN, BSE: 537291) is a Mumbai, Maharashtra-based company in the Grain And Field Beans industry. With a market capitalisation of ₹262 Cr, it ranks #2,440 by market cap among the 6,137 Indian listed companies on FinBizNet, and #13 of 38 in Grain And Field Beans. At ₹130.52 (as of 25 Oct 2026), the share price is 36.0% below its 52-week high of ₹204.00 and 3.5% above its 52-week low of ₹126.15. The share price is down 23.0% over one year and down 19.0% over three months.
| Current Price | ₹130.52 |
|---|---|
| Market Cap | ₹262 Cr |
| NSE Symbol | NATHBIOGEN |
| BSE Code | 537291 |
| Sector | Consumer Staples > Food, Beverage and Tobacco > Food Products |
| Sub-Industry | Agricultural Products and Services > Grain And Field Beans |
| P/E Ratio | 6.2 |
| Return on Equity | 6.28% |
| Return on Assets | 2.87% |
| 52-Week Range | ₹126.15 – ₹204.00 |
| 1-Year Price Change | -23.0% |
| 3-Month Price Change | -19.0% |
| Beta (1Y) | 0.22 |
| Dividend Yield | 1.47% |
| Headquarters | Mumbai, Maharashtra |
| Website | nathbiogenes.com |
| Revenue | ₹328 Cr |
|---|---|
| Net Profit | ₹32 Cr |
| Net Margin | 9.8% |
| EPS (Basic) | ₹16.98 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprising cabbage, chilli, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, sweet pepper, green peas, pumpkin, tinda, and French beans. It also provides crop protection supplements under the WINPro GOLii, WINall, and Win-Chi-Win names; and forage seeds under the NUTRIMAX GOLD and NUTRIMAX names. The company was founded in 1979 and is based in Mumbai, India.
1. Agriculture Activities-This segment engages in the seed production business. 2. Trading Activities-This segment engages in trading activities. 3. Research, Production and Processing of Seeds-This segment produces and sells seeds in India. It offers seeds for cereals, such as maize, paddy, pearl millet, sorghum, and wheat seeds; fiber and oil seeds, including cotton, mustard, and sunflower seeds; and seeds for vegetables comprising bitter gourd, bottle gourd, cabbage, cauliflower, chilly, coriander, cucumber, egg plant, okra, onion, ridge gourd, sponge gourd, tomato, and watermelon seeds.
1. Trading Activities-8.5% 2. Agriculture Activities-91.5%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Lt Foods Ltd. | ₹14,503 Cr | 22.6 | 14.94% | ₹3,152 Cr | -8.2% |
| Godrej Agrovet Ltd | ₹12,174 Cr | 25.8 | 18.68% | ₹2,855 Cr | -7.8% |
| KRBL Ltd | ₹9,024 Cr | 13.3 | 11.73% | ₹1,496 Cr | -7.6% |
| Gujarat Ambuja Exports | ₹7,987 Cr | 24.9 | 9.66% | ₹1,451 Cr | +43.9% |
| Grm Overseas Ltd. | ₹2,034 Cr | 26 | 14.38% | ₹427 Cr | -32.8% |
| Chaman Lal Setia Exports Ltd | ₹1,355 Cr | 11.4 | 14.61% | ₹346 Cr | +0.7% |
| Bombay Super Hybrid Seeds Ltdte | ₹997 Cr | 37.8 | 22.68% | ₹183 Cr | -32.5% |
| Mangalam Global Enterprise Limited (Mgel) | ₹561 Cr | 12.4 | 20.39% | ₹983 Cr | +10.2% |
| Nath Bio-Genes (India) Ltd | ₹262 Cr | 6.2 | 6.28% | ₹328 Cr | -23.0% |
Listed by market capitalisation. Ratios are shown for context only.
Nath Bio-Genes (India) Ltd is trading at ₹130.52, with a market capitalisation of ₹262 Cr.
Nath Bio-Genes (India) Ltd operates in the Consumer Staples > Food, Beverage and Tobacco > Food Products space (Agricultural Products and Services > Grain And Field Beans).
Nath Bio-Genes (India) Ltd has a P/E of 6.2 and a return on equity of 6.28%.
Nath Bio-Genes (India) Ltd is listed on the NSE under the symbol NATHBIOGEN and on the BSE under the scrip code 537291.
Nath Bio-Genes (India) Ltd's share price is down 23.0% over one year and down 19.0% over three months. Its 52-week range is ₹126.15 to ₹204.00.
In Q1 FY27, Nath Bio-Genes (India) Ltd reported revenue of ₹328 Cr and net profit of ₹32 Cr, with basic EPS of ₹16.98 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.